Year |
Citation |
Score |
2013 |
Muhlbradt E, Ma J, Severi G, Ortner E, Hayes V, Hoang HN, Stampfer M, Giles G, Pollak M, Gelmann EP. Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer. Genes & Cancer. 4: 535-45. PMID 24386513 DOI: 10.1177/1947601913506009 |
0.356 |
|
2009 |
Muhlbradt E, Asatiani E, Ortner E, Wang A, Gelmann EP. NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation. Cancer Research. 69: 2615-22. PMID 19258508 DOI: 10.1158/0008-5472.Can-08-3022 |
0.356 |
|
Low-probability matches (unlikely to be authored by this person) |
2024 |
Keenan C, Al-Haddawi M, Bienvenu JG, Bradley AE, Brown P, Chen H, Colman K, Elwell M, Gatto N, Goodman D, Jacob B, Lanning L, McKinney L, Muhlbradt E, Perry R, et al. Guide for Combining Primary Tumors for Statistical Analysis in Rodent Carcinogenicity Studies. Toxicologic Pathology. 1926233241230553. PMID 38445634 DOI: 10.1177/01926233241230553 |
0.066 |
|
2022 |
Facile R, Muhlbradt EE, Gong M, Li Q, Popat V, Pétavy F, Cornet R, Ruan Y, Koide D, Saito TI, Hume S, Rockhold F, Bao W, Dubman S, Jauregui Wurst B. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey. Jmir Medical Informatics. 10: e30363. PMID 35084343 DOI: 10.2196/30363 |
0.01 |
|
Hide low-probability matches. |